Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05752344

Enrollment

Registered

2023-03-02

Start date

2020-11-01

Completion date

2022-11-01

Last updated

2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystitis, Interstitial

Brief summary

The target population of this observational study is made up of all patients belonging to the Interstitial Cystitis pathway of the Gemelli University Hospital Foundation - IRCCS, who have accepted to be subjected to remote monitoring and diagnostic investigation. The aim of the study is the evaluation of some outcome parameters at the time of enrollment (T0), and at the end (T1) of subjects affected by Intersitial Cystitis who have carried out a monitoring of the dimensions of the psychic sphere concerning: depression, trait anxiety, state anxiety , well-being, self-efficacy, resilience.The objective is also to evaluate the presence of evolutionary and maturational trends in the mental set-up of the people who participated in the individual counseling intervention.

Interventions

OTHERCounseling

Professional Counseling is an activity that aims to improve the client's quality of life. Supporting his strengths and his ability to self-determination, Counseling offers a space for listening and reflection in which to explore difficulties, related to evolutionary processes, transition phase, states of crisis and reinforcement of the ability to choose or change.

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Recruited subjects have a diagnosis of Interstitial Cystitis and are 18 years of age or older.

Exclusion criteria

* Previous or current intellectual disability in accordance with the Diagnostic and Statistical Manual of Mental Disorders, DSM-5. * Patients who are unable to express consent and who do not have a caregiver who can give it for them.

Design outcomes

Primary

Measure	Time frame	Description
Gastrointestinal Symptom Rating Scale (GSCG)	12 months	Administration of psychometric scales
Hospital Anxiety and Depression Scale (HADS)	12 months	Administration of psychometric scales

Secondary

Measure	Time frame	Description
Psychological General Well-Being Index (PGWBI)	12 months	Administration of psychometric scales

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026